Edvan de Queiroz Crusoé

Universidade Federal da Bahia · BA · 50 publicações em 2022–2026

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia ResearchBone health and treatmentsMultiple Sclerosis Research StudiesLymphoma Diagnosis and Treatment

Principais coautores no Nordeste tamanho = publicações em comum

Marco Aurélio Salvino Alini Maria Orathes Ponte Silva Diego Lopes Paim Miranda Marianna Batista Vieira Lima Adrielle Gobi SABARIN David Pereira Ferreira Gabriela Cristina de Oliveira Herbert Henrique de Melo Santos Lais T. Silva Marianna Batista Vieira Lima Renata Cristina de Almeida Matos AG Sabarin

Publicações recentes

2026 9

Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial
Medicina · The Lancet
Dysregulation of the Bone Marrow Immune Microenvironment and Clinical Outcomes in Multiple Myeloma
Medicina · Immuno
Treatment outcome in pediatric patients with T-ALL in Brazil
Medicina · Leukemia Research
Brazilian consensus recommendations on the diagnosis and treatment of light chain amyloidosis
Medicina · Hematology Transfusion and Cell Therapy
LINFOMA DE ZONA MARGINAL E PLASMOCITOMA ÓSSEO SOLITÁRIO SINCRÔNICOS EM PACIENTE COM ARTRITE REUMATOIDE: RELATO DE CASO
Medicina · Hematology Transfusion and Cell Therapy
Real‐world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara‐VTd) induction and lenalidomide maintenance in transplant‐eligible multiple myeloma
Medicina · British Journal of Haematology
Innovations and inequalities: the challenge of access in multiple myeloma management in Brazil
Medicina · Hematology Transfusion and Cell Therapy
RESPOSTA CLÍNICA EXUBERANTE NÃO PREDIZ CONTROLE DURADOURO: RELATO DE LEUCEMIA MIELOIDE AGUDA (LMA) COM ACOMETIMENTO EXTRAMEDULAR EXTENSO, COM RECAÍDA PRECOCE APÓS TRANSPLANTE ALOGÊNICO
Medicina · Hematology Transfusion and Cell Therapy
VALIDAÇÃO DA DOENÇA RESIDUAL MENSURÁVEL DE ÚLTIMA GERAÇÃO EM PACIENTES COM MIELOMA MÚLTIPLO SUBMETIDOS A TRANSPLANTE AUTÓLOGO: UM ESTUDO MULTICÊNTRICO
Medicina · Hematology Transfusion and Cell Therapy

2025 11

Daratumumab-based quadruplet versus triplet induction regimens in transplant-eligible newly diagnosed multiple myeloma: a systematic review and meta-analysis
Medicina · Blood Cancer Journal
Practical Guidance on the Clinical Management of Ocular Adverse Events Associated with Belantamab Mafodotin for Patients with Relapsed/Refractory Multiple Myeloma: Latin American Expert Panel Recommendations
Medicina · Oncology and Therapy
Survival impact of anti-CD38-based quadruplet regimens in transplant-ineligible newly diagnosed multiple myeloma: a network meta-analysis and reconstructed individual patient data meta-analysis
Medicina · Blood Cancer Journal
Subcutaneous daratumumab plus carfilzomib and dexamethasone (D-Kd) versus carfilzomib and dexamethasone (Kd) in patients with relapsed/refractory multiple myeloma who received previous daratumumab treatment: LYNX study
Medicina · Leukemia & lymphoma/Leukemia and lymphoma
Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis
Medicina · Blood Advances
Bispecific Antibody Therapy for Multiple Myeloma: A Practical Toolkit
Medicina · Clinical Lymphoma Myeloma & Leukemia
Belantamab treatment of multiple myeloma: Results from part 1 of the first-in-human phase 1/2 DREAMM-20 trial.
Medicina · Journal of Clinical Oncology
Real-world data on the use of subcutaneous daratumumab plus bortezomib, thalidomide, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma
Medicina · Annals of Hematology
MAPPING AL AMYLOIDOSIS CHALLENGES IN BRAZIL: A BASIS FOR THE BRAZILIAN CONSENSUS RECOMMENDATIONS
Medicina · Hematology Transfusion and Cell Therapy
Survival impact of anti-CD38-based quadruplet regimens in transplant-ineligible newly diagnosed multiple myeloma: A network meta-analysis and reconstructed individual patient data meta-analysis
Medicina · Blood
LEUCEMIA MIELOMONOCÍTICA AGUDA EM PACIENTE COM DIAGNÓSTICO RECENTE DE ADENOCARCINOMA DE RETO: RELATO DE CASO
Medicina · Hematology Transfusion and Cell Therapy

2024 11

Delayed Neurotoxicity after CAR-T in Multiple Myeloma: Results from a Global IMWG Registry
Medicina · Blood
Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study
Medicina · Blood Advances
Variability in the perception of palliative care and end-of-life care among hematology professionals from the same reference center in Bahia, Brazil: A descriptive cross-sectional study
Medicina · Sao Paulo Medical Journal
REAL-WORLD DATA ON THE DARATUMUMAB PLUS BORTEZOMIB, THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY LENALIDOMIDE MAINTENANCE FOR TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
Medicina · Hematology Transfusion and Cell Therapy
Daratumumab-Based Quadruplet Versus Triplet Induction Regimens in Frontline Transplant-Eligible Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis
Medicina · Blood
Use of Teclistamab Outside of Clinical Trials in Latin America: Risk of Infections and Immunoglobulin Replacement
Medicina · Blood
MM-722 Lymphocyte Profiling in Newly Diagnosed Multiple Myeloma: First-Line Treatment with Cyclophosphamide Thalidomide, Dexamethasone, and Daratumumab
Medicina · Clinical Lymphoma Myeloma & Leukemia
The Brazilian association of hematology, hemotherapy, and cell therapy (ABHH) and its absolute commitment to ethics and absence of conflicts of interest
Enfermagem · Hematology Transfusion and Cell Therapy
ESTUDO DE VIDA REAL COMPARANDO FLUDARABINA+ CITARABINA+ ANTRACICLINA COM E SEM VENETOCLAX, EM PACIENTES COM LEUCEMIA MIELOIDE AGUDA RECIDIVADO/REFRATÁRIO, EM UMA INSTITUIÇÃO PÚBLICA NO BRASIL.
Medicina · Hematology Transfusion and Cell Therapy
Smoldering Multiple Myeloma in Latin America- Risk Stratification
Medicina · Blood
SMOLDERING MULTIPLE MYELOMA IN LATIN AMERICA
Medicina · Hematology Transfusion and Cell Therapy

2023 10

Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients
Medicina · Cancers
COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality –cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM)
Medicina · Hematology Transfusion and Cell Therapy
The Impact of Isatuximab Regimens on Hypogammaglobulinemia Occurrence, Recovery, and Associated Infections in Patients with Relapsed/Refractory Multiple Myeloma
Medicina · Blood
P954: MULTIPLE MYELOMA IN LATIN AMERICA CANCER REGISTRY: THE MYLACRE STUDY
Medicina · HemaSphere
Major Challenges for Palliative Care in Oncohematology: Analysis of the “Surprise Question” in a Reference Center
Medicina · Blood
Challenges to achieving BMT in the treatment of AML in Brazil
Medicina · JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
HSCT FOR MONOCLONAL GAMMOPATHIES: MULTIPLE MYELOMA AND AMYLOIDOSIS
Medicina · JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
LONG-TERM OUTCOMES WITH ISATUXIMAB-CARFILZOMIB-DEXAMETHASONE IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH 1Q21+ STATUS: UPDATED RESULTS FROM THE PHASE 3 IKEMA STUDY
Medicina · Hematology Transfusion and Cell Therapy
Equity program: strategies on clinical studies as an aggregating potential
Medicina · Hematology Transfusion and Cell Therapy
Real World Evidence- the Proportion of Myeloma Patients' Death Due to Early Progression
Medicina · Blood

2022 9

Monoclonal gammopathy of renal significance (MGRS): Real‐world data on outcomes and prognostic factors
Medicina · American Journal of Hematology
CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil
Medicina · Hematology Transfusion and Cell Therapy
Impact of the lactate dehydrogenase in association with the International Staging System prognostic score in multiple myeloma patients treated in real life
Medicina · Hematology Transfusion and Cell Therapy
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira – 2022. Part I
Medicina · Hematology Transfusion and Cell Therapy
Lambda light chain-induced monoclonal gammopathy of renal significance, manifesting with Fanconi Syndrome and osteomalacia
Medicina · BMC Nephrology
PB1993: MULTIPLE MYELOMA BRAZILIAN REGISTER- HOW ABOUT THE TRANSPLANT ELIGIBLE PATIENTS?
Medicina · HemaSphere
Variability in End-of-Life Care and Perception of Palliative Care Among Physicians in the Hematology Unit of a Reference Service in the State of Bahia, Brazil
Medicina · Blood
P890: THE OUTCOME OF SECOND PRIMARY MALIGNANCIES DEVELOPING IN MM PATIENTS
Medicina · HemaSphere
Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone for Transplant Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients: Response Rate Impacts on PFS
Medicina · Blood

Contagens só com publicações em revistas com Qualis (filtro na tela inicial). Dados obtidos de fontes abertas: OpenAlex (CC0), ROR (CC0), CAPES Dados Abertos (CC-BY), INEP e IBGE. Encontrou um erro sobre você? Saiba mais. Criado por Gabriel Pina.